Panel Session: Navigating Next-Generation Clinical Development: Charting Tomorrow

Session details:

Clinical development is being reshaped by AI, evolving regulatory expectations, and new ecosystem dynamics—with the potential to cut cost and timelines in half by 2030. However, success will depend on rethinking operating models, governance structures, and partnerships that enable agility, resilience and execution at scale. This panel will discuss:

• The most critical trends shaping the next decade of drug development and how industry can make bold goals a reality
• How biopharma leaders can navigate and define the future of drug development to deliver programs that are faster, more efficient, and more site- and patient-focused
• How to adapt to real-time regulatory oversight, leverage tech-driven efficiencies, evolve operating models, and prepare R&D portfolios for the clinical realities of 2030 and beyond

Speakers: TBA